Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290848
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290848
Induced Pluripotent Stem Cell (iPSC) Market with COVID-19 Impact Analysis, By Derived Cell, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 402 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Induced Pluripotent Stem Cell (iPSC) Market size was valued at USD 2,005.3 million in 2022, expanding at a CAGR of 7.1% from 2023 to 2030.
Induced Pluripotent Stem cells (iPSC) are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient, or neurons to treat neurological disorders. iPSC have certain advantages over other stem cell types in models of regenerative medicine and wound healing. Because they are derived from adult somatic cells, and not embryos, iPSC are not associated with the ethical dilemmas surrounding the use of embryonic stem cells.
Induced Pluripotent Stem Cell (iPSC) Market- Market Dynamics:
Rising demand for vaccine production especially after the onslaught of the pandemic, and increasing investments in the iPSC sector are some of the factors contributing towards rapid iPSC market growth.
The pandemic has also emphasized the importance of cell-based therapies for treating diseases. iPSCs offer a renewable source of cells that can be differentiated into various cell types for therapeutic applications. This includes the potential use of iPSCs for developing cell-based therapies to treat COVID-19-related complications, such as lung damage. According to World health organization, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Many governments recognize the potential of iPSC technology and have initiated funding programs to support research and commercialization efforts. iPSC-derived cells provide a consistent and scalable platform for vaccine production, enabling faster and more efficient vaccine manufacturing processes.
Induced Pluripotent Stem Cell (iPSC) Market- Key Insights:
- As per the analysis shared by our research analyst, the global Induced Pluripotent Stem Cell (iPSC) market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
- The Induced Pluripotent Stem Cell (iPSC) industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on type segmentation, Cardiomyocytes were predicted to show maximum market share in the year 2022
- Based on Application segmentation, Drug development, and discovery were the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Induced Pluripotent Stem Cell (iPSC) Market- Segmentation Analysis:
- The Global Induced Pluripotent Stem Cell (iPSC) Market is segmented on the basis of derived cells, Application, and Region.
- The market is divided into three categories based on derived cells: Hepatocytes, Fibroblasts. Amniotic Cells, Cardiomyocytes, and Others. Cardiomyocytes dominate the market. Patient-specific iPSC-derived Cardiomyocytes (iPSC-CMs) offer an attractive experimental platform to model cardiovascular diseases, study the earliest stages of human development, accelerate predictive drug toxicology tests, and advance potential regenerative therapies.
- The market is divided into two categories based on application: Manufacturing, Academic Research, Drug Development & Discovery, Toxicity Screening, and Regenerative Medicine. Drug development and discovery dominate the market and are likely to maintain its dominance during the forecast period. Induced pluripotent stem cell (iPSC) technology is revolutionizing medical science, allowing the exploration of disease mechanisms and novel therapeutic molecular targets, and offering opportunities for drug discovery and proof-of-concept studies in drug development.
Induced Pluripotent Stem Cell (iPSC) Market- Geographical Insights:
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to dominate the Induced Pluripotent Stem Cell (iPSC market, due to the prevalence of chronic disease and the use of Stem Cell in their treatment. According to center of disease control and prevention, in 2018, 51.8% (129 million) of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. iPSCs hold tremendous potential for developing personalized therapies and disease modeling in these areas. The demand for advanced treatments and innovative therapies to address chronic diseases drives the growth of the iPSC market in this region. Overall, Europe and Asia, are also actively participating in iPSC research and development.
Induced Pluripotent Stem Cell (iPSC) Market- Competitive Landscape:
The United States, South Korea, Japan, the United Kingdom, and China have emerged as the top five countries for stem cell treatment, recognitions to their commitment to advancing the field and providing innovative treatment options for patients. There are just a few examples of prominent players in the iPSC market. Other companies, academic institutions, and research organizations worldwide are actively engaged in iPSC research, product development, and clinical trials. For example, 27 Jan,2021 Thermo Fisher Scientific has developed a new medium for the development and expansion of human T lymphocytes (T-cells) for cell therapy developers using allogeneic workflows. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions.
Recent Developments:
In November 2021, Ncardia (Gosselies, Belgium), a leading human-induced pluripotent stem cell (iPSC) technology company, has recently announced their partnership with investment platform Kiniciti (NY, USA) - a collaboration which will facilitate the development of innovative iPSC-derived advanced therapies.
Key features of the study:
- This proposed research study on Induced Pluripotent Stem Cell (iPSC) market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Induced Pluripotent Stem Cell (iPSC) market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Induced Pluripotent Stem Cell (iPSC) market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Induced Pluripotent Stem Cell (iPSC) market
- Impact of COVID-19 on Induced Pluripotent Stem Cell (iPSC) market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Induced Pluripotent Stem Cell (iPSC) market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Induced Pluripotent Stem Cell (iPSC) market, we have also included competitive landscape and key innovator analysis for the Induced Pluripotent Stem Cell (iPSC) market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Induced Pluripotent Stem Cell (iPSC) market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Induced Pluripotent Stem Cell (iPSC) market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET KEY PLAYERS
- Lonza
- Axol Biosciences Ltd.
- Evotec SE
- Hitachi Ltd.
- Merck KGaA
- REPROCELLS, Inc.
- Fate Therapeutics
- Thermo Fisher Scientific, Inc.
- StemCellsFactory III
- Applied StemCells, Inc.
GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY DERIVED CELL
- Hepatocytes
- Fibroblasts
- Amniotic Cells
- Cardiomyocytes
- Others
GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY APPLICATION
- Manufacturing
- Academic Research
- Drug Development & Discovery
- Toxicity Screening
- Regenerative Medicine
GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1294
Table of Contents
1. Induced Pluripotent Stem Cell (iPSC) Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Derived Cells
- 2.1.2. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Application
- 2.1.3. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Country
- 2.1.4. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Region
- 2.2. Competitive Insights
3. Induced Pluripotent Stem Cell (iPSC) Key Market Trends
- 3.1. Induced Pluripotent Stem Cell (iPSC) Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Induced Pluripotent Stem Cell (iPSC) Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Induced Pluripotent Stem Cell (iPSC) Market Opportunities
- 3.4. Induced Pluripotent Stem Cell (iPSC) Market Future Trends
4. Induced Pluripotent Stem Cell (iPSC) Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Induced Pluripotent Stem Cell (iPSC) Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Induced Pluripotent Stem Cell (iPSC) Market Landscape
- 6.1. Induced Pluripotent Stem Cell (iPSC) Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Induced Pluripotent Stem Cell (iPSC) Market - By Derived cells
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Derived cells, 2022 & 2030 (%)
- 7.1.2. Standard Steel Induced Pluripotent Stem Cell (iPSC)
- 7.1.3. Non-magnetic Induced Pluripotent Stem Cell (iPSC)
8. Induced Pluripotent Stem Cell (iPSC) Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Onshore
- 8.1.3. Offshore
9. Induced Pluripotent Stem Cell (iPSC) Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Induced Pluripotent Stem Cell (iPSC) Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Lonza
- 10.2.2. Axol Biosciences Ltd.
- 10.2.3. Evotec SE
- 10.2.4. Hitachi Ltd.
- 10.2.5. Merck KGaA
- 10.2.6. REPROCELLS, Inc.
- 10.2.7. Fate Therapeutics
- 10.2.8. Thermo Fisher Scientific, Inc.
- 10.2.9. StemCellsFactory III
- 10.2.10. Applied StemCells, Inc.
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
Product Code: ANV1294
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Induced Pluripotent Stem Cell (iPSC) Market: Derived cells Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Derived cells
- TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells 2018-2030 (USD Million)
- TABLE Induced Pluripotent Stem Cell (iPSC) Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Application 2018-2030 (USD Million)
- TABLE Induced Pluripotent Stem Cell (iPSC) Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Region 2018-2030 (USD Million)
- TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
- TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
- TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
- TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
- TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
- TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
- TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
List of Figures
- FIGURE Induced Pluripotent Stem Cell (iPSC) Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Derived cells segment market share analysis, 2022 & 2030
- FIGURE Derived cells segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Application segment market share analysis, 2022 & 2030
- FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Technology segment market share analysis, 2022 & 2030
- FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
- FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
- FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
- FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
- FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
- FIGURE Germany Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
- FIGURE India Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
- FIGURE Brazil Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
- FIGURE Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.